In This Section

CEWG Steering Committee

M. William Audeh, MD, MS

M. William Audeh, MD, MS

(2021-2024)

Chief Medical Officer
Agendia, Inc.
Irvine, California
Medical Staff Member
Cedars-Sinai Medical Center
Los Angeles, California

Alberto Bardelli, PhD

Alberto Bardelli, PhD

(2021-2024)

Full Professor, Department of Oncology
University of Torino
Director, Laboratory of Molecular Oncology
Candiolo Cancer Institute
Candiolo, Italy

Michael C. Campbell, PhD

Michael C. Campbell, PhD

(2021-2024)

Assistant Professor, Department of Biology
Howard University
Washington, D.C.

Peter J. Campbell, MBChB, PhD

Peter J. Campbell, MBChB, PhD

(2021-2024)

Head of Cancer, Ageing and Somatic Mutation
Senior Group Leader
Wellcome Trust Sanger Institute
Hinxton, Cambridgeshire, United Kingdom

Christina Curtis, PhD

Christina Curtis, PhD

(2021-2024)

Associate Professor of Medicine and Genetics
Stanford University School of Medicine
Co-director, Molecular Tumor Board
Stanford Cancer Institute
Stanford, California 

James V. DeGregori, PhD

James V. DeGregori, PhD

(2021-2024)

Professor, Department of Biochemistry and Molecular Genetics
University of Colorado School of Medicine
Aurora, Colorado

Robert A. Gatenby, MD

Robert A. Gatenby, MD

(2021-2024)

Chair, Department of Radiology
Co-director, Cancer Biology and Evolution Program
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida

Marco Gerlinger, MD

Marco Gerlinger, MD

(2021-2024)

Team Leader, Translational Oncogenomics Laboratory
Centre for Evolution and Cancer
The Institute of Cancer Research
London, United Kingdom

Michael A. Gillette, MD, PhD

Michael A. Gillette, MD, PhD

(2021-2024)

Senior Group Leader, Proteomics and Biomarker Discovery
Broad Institute of MIT and Harvard
Cambridge, Massachusetts

Robert J. Gillies, PhD

Robert J. Gillies, PhD

(2021-2024)

Chair, Department of Cancer Physiology
H. Lee Moffitt Cancer Center and Research Institute
Tampa, Florida

Trevor Graham, PhD

Trevor Graham, PhD

(2021-2024)

Professor of Cancer Evolution
Deputy Centre Lead and Group Leader
Barts Cancer Institute
London, United Kingdom

Henry H.Q. Heng, PhD

Henry H.Q. Heng, PhD

(2021-2024)

Professor of Molecular Medicine, Genetics and Pathology
Karmanos Cancer Institute 
Wayne State University School of Medicine
Detroit, Michigan

Giulia C. Kennedy, PhD

Giulia C. Kennedy, PhD

(2021-2024)

Chief Scientific Officer and Chief Medical Officer
Veracyte, Inc.
San Francisco, Calfornia

Carlo C. Maley, PhD

Carlo C. Maley, PhD

(2021-2024)

Director, Arizona Cancer and Evolution Center;
Associate Professor, Biodesign Institute and School of Life Sciences
Arizona State University
Tempe, Arizona

Perry S. Marshall, BS

Perry S. Marshall, BS

(2021-2024)

Marketing Consultant and Author
Chicago, Illinois

Andriy Marusyk, PhD

Andriy Marusyk, PhD

(2021-2024)

Associate Professor
Department of Cancer Physiology
Moffitt Cancer Center
Tampa, Florida

Nicholas McGranahan, PhD

Nicholas McGranahan, PhD

(2021-2024)

Professor
University College London
London, England, United Kingdom

Franziska Michor, PhD

Franziska Michor, PhD

(2021-2024)

Professor of Computational Biology
Departments of Data Sciences, Biostatistics, and Stem Cell and Regenerative Biology
Dana-Farber Cancer Institute
Harvard T.H. Chan School of Public Health, Harvard University
Boston, Massachusetts

Paul S. Mischel, MD

Paul S. Mischel, MD

(2021-2024)

Professor and Vice Chair of Research
Department of Pathology
Stanford University School of Medicine
Stanford, California

Nicholas E. Navin, PhD

Nicholas E. Navin, PhD

(2021-2024)

Associate Professor
Departments of Bioinformatics and Genetics, Division of Basic Science Research
Director, CPRIT Single Cell Genomics Center
Co-Director, Advanced Technology Genomics Core
University of Texas MD Anderson Cancer Center
Houston, Texas

Serena Nik-Zainal, MBBCh, PhD

Serena Nik-Zainal, MBBCh, PhD

(2021-2024)

CRUK Advanced Clinician Scientist
Honorary Consultant in Clinical Genetics
University of Cambridge
Cambridge, United Kingdom

Larry Norton, MD, FAACR

Larry Norton, MD, FAACR

(2021-2024)

Department Physician-In-Chief
Breast Cancer Program
Memorial Sloan Kettering Cancer Center
New York, New York

Elizabeth O’Day, MPhil, PhD

Elizabeth O’Day, MPhil, PhD

(2021-2024)

Founder and Chief Executive Officer
Olaris Therapeutics, Inc.
Waltham, Massachusetts

Azra Raza, MD

Azra Raza, MD

(2021-2024)

Chan Soon-Shiong Professor of Medicine
Director, Myelodysplastic Syndrome Center
Columbia University
New York, New York

Andrea Sottoriva, PhD

Andrea Sottoriva, PhD

(2021-2024)

Head of the Centre for Computational Biology
Human Technopole
Milan, Italy
Director, Centre for Evolution and Cancer
The Institute of Cancer Research
London, United Kingdom

Jonathan Weissman, PhD

Jonathan Weissman, PhD

(2021-2024)

Landon T. Clay Professor of Biology
Member, Whitehead Institute
Investigator
Howard Hughes Medical Institute
Cambridge, Massachusetts

Danny R. Welch, PhD

Danny R. Welch, PhD

(2021-2024)

Professor of Cancer Biology
University of Kansas Cancer Center
Kansas City, Kansas